The following table provides an overview of the latest patents of Sloan Kettering Institute For Cancer Research that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3533792May 5, 2021Crystalline Forms Of An Androgen Receptor Modulator1